VRAX · Virax Biolabs Group Ltd
Market Cap
$2.25M
Shares
796,988
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-26 | 2026-08-21 | |
| 6-K | 2026-08-18 | — | |
| 6-K | 2026-07-31 | — | |
| 6-K | 2026-07-16 | — | |
| 6-K | 2026-07-10 | — | |
| 6-K | 2026-07-09 | — | |
| 20-F | 2026-07-06 | 2026-03-31 | |
| 6-K | 2026-06-24 | — | |
| 6-K | 2026-06-12 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-22 | — | |
| 6-K | 2026-04-14 | — | |
| 6-K | 2026-04-10 | — | |
| 6-K | 2026-03-18 | — | |
| 6-K | 2026-01-30 | — | |
| 6-K | 2025-12-04 | — | |
| 6-K | 2025-12-02 | — | |
| 6-K | 2025-07-30 | — | |
| 20-F | 2025-07-02 | 2025-03-31 | |
| 6-K | 2025-06-13 | — | |
| 6-K | 2025-03-18 | — | |
| 6-K | 2025-03-13 | — | |
| 6-K | 2025-03-05 | — | |
| 6-K | 2025-02-25 | — | |
| 6-K | 2024-12-23 | — | |
| 6-K | 2024-12-17 | — | |
| 6-K | 2024-12-10 | — | |
| 6-K | 2024-11-20 | — | |
| 6-K | 2024-10-31 | — | |
| 6-K | 2024-10-23 | — | |
| 6-K | 2024-09-30 | — | |
| 6-K | 2024-08-23 | — | |
| 20-F | 2024-08-20 | 2024-03-31 | |
| 6-K | 2024-06-11 | — | |
| 6-K | 2024-04-25 | — | |
| 6-K | 2024-04-16 | — | |
| 6-K | 2024-03-15 | — | |
| 6-K | 2024-01-22 | — | |
| 6-K | 2024-01-12 | 2024-01-11 | |
| 6-K | 2023-12-21 | — | |
| 6-K | 2023-12-20 | — | |
| 6-K | 2023-12-18 | — | |
| 6-K | 2023-12-14 | — | |
| 6-K | 2023-12-08 | — | |
| 6-K | 2023-11-08 | — | |
| 6-K | 2023-10-31 | — | |
| 6-K | 2023-10-12 | — | |
| 6-K | 2023-10-04 | — | |
| 6-K | 2023-09-12 | — | |
| 6-K | 2023-09-01 | — |
Showing 1–50 of 76 filings